EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Tumor promoting phorbol ester derivatives increase ornithine decarboxylase ec 4.1.1.17 activity and poly amine biosynthesis in the liver of the rat and mouse



Tumor promoting phorbol ester derivatives increase ornithine decarboxylase ec 4.1.1.17 activity and poly amine biosynthesis in the liver of the rat and mouse



Carcinogenesis (Oxford) 3(7): 751-756



The ability of the phorbol-ester tumor promoters to alter ornithine decarboxylase (ODC) activity in the liver of the rat and mouse was determined. The injection of 12-O-tetradecanoyl phorbol-13-acetate (TPA, 100 .mu.g, i.p.) led to a 250-fold increase in hepatic ODC activity within 4 h of administration. This increase in ODC activity required both RNA and protein synthesis and did not occur when a variety of the non-tumor promoting phorbol-ester derivatives were administered to the rat. A distinct dose-dependent increase in hepatic ODC activity could be observed at 4 h following the injection of increasing amounts of TPA (0-100 .mu.g, i.p.). As little as 1.0 .mu.g TPA (i.p.) administered to a rat resulted in a significant stimulation in the activity of ODC in the liver compared to the control unstimulated values. Both 200 .mu.g and 500 .mu.g TPA produced less of an elevation in hepatic ODC activity than did the optimal dose of 100 .mu.g. In the mouse, the administration of 1 .mu.g and 20 .mu.g of TPA (i.p.) both led to a marked increase in hepatic ODC activity at 7 h and 4 h, respectively, following injection. A 4- to 5-fold increase in putrescine levels occurred in the rat liver in a biphasic manner between 4-8 h and 16-24 h following the injection of TPA (100 .mu.g). No alterations in either spermidine or spermine were observed during this period. The administration of 100 .mu.g of TPA to the rat did not alter the incorporation of [3H]thymidine into DNA in the liver compared to untreated control animals. Under these identical conditions partial hepatectomy led to a large increase in DNA synthesis.

(PDF 0-2 workdays service: $29.90)

Accession: 006847397

Download citation: RISBibTeXText



Related references

Tumor promoting phorbol-ester derivatives increase ornithine decarboxylase activity and polyamine biosynthesis in the liver of the rat and mouse. Carcinogenesis 3(7): 751-755, 1982

Poly amine biosynthesis and skin tumor promotion inhibition of 12 o tetradecanoyl phorbol 13 acetate promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase ec 4.1.1.17 alpha di fluoromethyl ornithine. Biochemical and Biophysical Research Communications 105(3): 969-976, 1982

Tumor-promoting phorbol ester amplifies the inductions of tyrosine aminotransferase and ornithine decarboxylase by glucocorticoid. Biochemistry 26(8): 2349-2353, 1987

The induction of ornithine decarboxylase ec 4.1.1.37 by tumor promoting phorbol ester analogs in reuber h 35 hepatoma cells. Life Sciences 29(18): 1855-1864, 1981

The induction of ornithine decarboxylase by tumor promoting phorbol ester analogues in Reuber H35 hepatoma cells. Life Sciences 29(18): 1855-1863, 1981

Characterization of arginase activity from mouse epidermis and its relation to ornithine decarboxylase ec 4.1.1.17 induction by the tumor promoting agent 12 o tetradecanoyl phorbol 13 acetate. Biochimica et Biophysica Acta 677(2): 184-189, 1981

Inhibition of emt 6 tumor growth by interference with poly amine biosynthesis effects of alpha di fluoromethyl ornithine an irreversible inhibitor of ornithine decarboxylase ec 4.1.1.17. Life Sciences 26(3): 181-194, 1980

Effects of 1 25 dihydroxyvitamin d 3 and fluorinated analog on the ornithine decarboxylase activity and its gene expression in mouse skin induced by phorbol ester tumor promoter. Clinical Research 37(2): 629A, 1989

Relationship between ornithine decarboxylase-inducing activity and configuration at C-4 in phorbol ester derivatives. Journal of Cancer Research and Clinical Oncology 98(1): 9-13, 1980

Alpha di fluoromethyl ornithine an irreversible inhibitor of ornithine decarboxylase ec 4.1.1.17 inhibits tumor promoter induced poly amine accumulation and carcinogenesis in mouse skin. Proceedings of the National Academy of Sciences of the United States of America 79(19): 6028-6032, 1982

Relationship between ornithine decarboxylase inducing activity and configuration at carbon 4 in phorbol ester derivatives. Journal of Cancer Research & Clinical Oncology 98(1): 9-14, 1980

Inhibition of phorbol ester-induced ornithine decarboxylase gene transcription by retinoic acid: a possible mechanism of antitumor promoting activity of retinoids. Progress in Clinical and Biological Research 259: 245-260, 1988

Ability of the non-phorbol ester-type tumor-promoter thapsigargin to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo. International Journal of Cancer 55(6): 1036-1043, 1993

Effects of the tumor promoter 12 o tetra decanoyl phorbol 13 acetate and serum on ornithine decarboxylase induction and poly amine synthesis in normal and transformed fibroblasts. Journal of Cell Biology 83(2 PART 2): 106A, 1979